Vimarsana
Biggest News Aggregation in the World

Page 7 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aadi Bioscience Today - Breaking & Trending Today

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 25,569 Shares - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 25,569 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 25,569 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $4.37, for a total value of $111,736.53. Following the transaction, the chairman now directly owns 1,637,974 shares of the company’s stock, […]

Aadi Bioscience : Corporate Presentation -October 06, 2023 at 04:02 pm EDT - Vimarsana News

Aadi Bioscience : Corporate Presentation -October 06, 2023 at 04:02 pm EDT

Corporate Presentation October 2023 Forward-Looking Statements ...

Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium - Vimarsana News

Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...

Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) - Vimarsana News

Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...

Stocks That Hit 52-Week Lows On Tuesday - Glimpse Group (NASDAQ:VRAR), Vor Biopharma (NASDAQ:VOR) - Vimarsana News

Stocks That Hit 52-Week Lows On Tuesday - Glimpse Group (NASDAQ:VRAR), Vor Biopharma (NASDAQ:VOR)

  On Tuesday, 647 companies set new 52-week lows.